See how top analysts and institutions rate RBLX — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| MoffettNathanson | Upgrade | Sell → Neutral | 2025-10-09 | |
| Citigroup | Reiterated | Buy | $152 → $155 | 2025-10-08 |
| Arete | Upgrade | Sell → Neutral | $116 | 2025-09-09 |
| Wolfe Research | Upgrade | Peer Perform → Outperform | $150 | 2025-08-22 |
| Raymond James | Downgrade | Strong Buy → Outperform | $130 | 2025-07-23 |
| JP Morgan | Reiterated | Overweight | $120 → $125 | 2025-07-16 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 8 | 15 | 7 | 1 | 1 |
| October 2025 | 7 | 15 | 7 | 2 | 0 |
| September 2025 | 7 | 15 | 7 | 2 | 0 |
| August 2025 | 7 | 15 | 6 | 3 | 0 |
The majority of institutional investors have issued a "Buy" rating for RBLX, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
